HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trend of Balkan endemic nephropathy patients on renal replacement therapy in Bosnia from 2003 through 2005.

Abstract
The aim of this study is to evaluate epidemiological status of Balkan endemic nephropathy (BEN) patients on renal replacement therapy (RRT) in Bosnia from 2003 through 2005. Incidence and prevalence rates of BEN, diabetes mellitus (DM) and RRT population and proportion of BEN RRT population in total RRT population were tracked in renal units covering the entire BEN endemic region in Bosnia. BEN incidence and prevalence rates were 52; 34;48 and 262; 265, 292, respectively. DM incidence and prevalence rates were 7; 13; 8 and 20; 28; 33, respectively. Total RRT population incidence and prevalence rates were 89; 82; 79 and 424; 436; 473, respectively. Proportions of incident BEN RRT population in incident total RRT population and proportions of incident BEN RRT population in incident total RRT population when incident diabetics were subtracted from incident total RRT population were 0.58; 0.41; 0.61, and 0.63; 0.49; 0.67; respectively. Proportions of prevalent BEN RRT population in prevalent total RRT population and proportions of prevalent BEN RRT population in prevalent total RRT population when prevalent diabetics were subtracted from prevalent total RRT population were 0.62; 0.61; 0.62, and 0.65; 0.65; 0.66, respectively. Trend of BEN RRT population was stable in Bosnia from 2003 through 2005.
AuthorsGoran Imamović, Enver Zerem, Safet Omerović
JournalBosnian journal of basic medical sciences (Bosn J Basic Med Sci) Vol. 7 Issue 4 Pg. 372-6 (Nov 2007) ISSN: 1512-8601 [Print] Bosnia and Herzegovina
PMID18039199 (Publication Type: Journal Article)
Topics
  • Bosnia and Herzegovina
  • Diabetes Complications (therapy)
  • Diabetic Nephropathies (diagnosis, epidemiology, therapy)
  • Humans
  • Kidney Diseases (diagnosis, epidemiology, therapy)
  • Prevalence
  • Prospective Studies
  • Registries
  • Renal Replacement Therapy (adverse effects)
  • Research Design
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: